,0,1
Business Ethics,"The frequency of the Board actively reviewing the sufficiency of resources allocated to the global anti-corruption and briberyprogram including the compliancefunction. The Board Chair and CEO, and Chief Compliance & Ethics Officer (CCEO), communicate several times each year on integrity-related topics. All employees must read and sign off on the Principles of Integrity: BMS Standards of Business Conduct and Ethics.The program is adequately resourced and empowered to function effectively. The company has established anti-corruption compliance KPIs that are used to measure the compliance program. 98 .5% employees completed Principles ofIntegrity course 2020-2021 (2-year cadence) 2021 ESG REPORT | 10Ethical BusinessBMS Codes of Conduct GRI 102-17 (Comprehensive) Internal and external mechanisms for reporting concerns about unethical or unlawful behavior, and matters related to organizational integrity. Process for evaluating the highest governance body's own performance with respect to economic, environmental and social topics.100% of business functions are represented in BMS anti-corruption risk assessments. Compliance standards are memorialized in third-party agreements. The Compliance & Ethics department publishes regular companywide memos and articles on the internal news platform.","4.5The frequency of the Board actively reviewing the sufficiency of resources allocated to the global anti-corruption and briberyprogram including the compliancefunctionOur CCEO presents to, and has private sessions with, the Audit Committee several times a year. The Board Chair and CEO, and Chief Compliance & Ethics Officer (CCEO), communicate several times each year on integrity-related topics including company values, our Principles of Integrity, and anti-bribery policy training and compliance. For instance, our CEO and Chief Compliance and Ethics Officer (CCEO) circulate communications on integrity-related topics, including our company values, principles of integrity, and compliance and training surrounding our anti-bribery policies. To support our anti-corruption program, robust anti-bribery policies apply to all BMS employees and relevant contractors, and all undergo comprehensive education and training on the subject. Business EthicsTotal amount of monetary losses as a result of legal proceedings associated with corruption and bribery. First-line business owners establish systems and processes with anti-corruption controls; second-line functions such as Compliance and the Controller monitor relevant activities for anti- corruption compliance; and the independent internal audit function reviews first- and second-line activities. GRI Content Index GRI 102-55 GRI content index GRI Content Index GRI 102-56 External assurance Verification Statements GRI 103-1 Boundary of the report within the organization and specific limitations2021 ESG Report: About This Report GRI 103-2 The management approach and its components 2021 ESG Report: About This Report; Introduction >> Our Approach to ESG GRI 103-3 Evaluation of the management approach Board Committee & Charters Committee on Directors and Corporate Governance CharterResponsibilities and Duties Items 15 and 17 GRI 201-1 Direct economic value generated and distributed, including revenues, operating costs, employee compensation, donations and other community investments, retained earnings, and payments to capital providers and governments2021 10-K Fair Value Measurement, pages 52, 56, 68-69 Accrued Employee Compensation and Benefits, page 104 Dividends, pages 35, 37 Interest, page 37 Chargebacks related to government programs, pages 44-45, 77 Corporate Giving Economic Performance GRI 201-2 Financial implications and other risks and opportunities for the organization's activities due to climate change2021 ESG Report: Environmental Responsibility >> Energy and Emissions CDP Bristol Myers Squibb Position Statement on Climate Change GRI 201-3 Coverage of the organization's defined benefit plan obligations2021 10-K , pages 107-115 GRI 203-1 Development and impact of infrastructure investments and services supportedBristol Myers Squibb Foundation GRI 203-2 Significant indirect economic impacts, including the extent of impacts2021 ESG Report: Innovation, Equity and Access to Healthcare 2021 ESG REPORT | 67 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 205-2 Percentage of employees trained in anti-corruption policies/procedures2021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical Business Our Principles All employees must read and sign off on the Principles of Integrity: BMS Standards of Business Conduct and Ethics as a condition of employment. This report also includes our Anti-Corruption report using the Norges Bank Investment Management (NBIM) guidance, providing additional transparency to our progress in this critical area. 4.4The program is adequately resourced and empowered to function effectivelyBMS Compliance & Ethics organization and its relevant partners are fully resourced to deliver on our anti- corruption compliance program priorities. 2.3The company has established anti-corruption compliance KPIs that are used to measure the compliance programSeveral risk management functions capture and track metrics related to anti-corruption compliance. 3.3Percentage of third parties that improve their anti-corruption compliance programsA vast majority (>95%) of third parties improve their anti-corruption programs in response to our findings, and doing so is a critical factor for BMS to continue its relationship with a third party. 27,059 employees assigned with Principlesof Integrity course 98.5% employees completed Principles ofIntegrity course 2020-2021 (2-year cadence) 2021 ESG REPORT | 10Ethical Business Operating with ethics and integrity is foundational to our business and our commitment to sustainable growth. We operate with effective governance and the highest ethical standards, and we seek transparency and dialogue with our stakeholders to improve our understanding of their needs. GRI 102-11 Explanation of whether and how the precautionary approach or principle is addressed by the organization2021 ESG Report: Introduction >> UN Sustainable Development Goals >> Standing Up for Human Rights; Ethics, Integrity, Quality and Governance >> Governance and Risk Management; Ethical and Safe Products GRI 102-12 External charters, principles, initiatives Overarching Policies Voluntary standards GRI 102-13 Memberships in associations Stakeholder Engagement Business association memberships GRI 102-14 Statement from senior management 2021 ESG Report: CEO Letter GRI 102-15 (Comprehensive)Description of key impacts, risks, and opportunities 2021 10-K 2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management GRI 102-16 Internally developed statements of mission or values, codes of conduct, codes of ethics, and principles relevant to sustainable developmentBMS Codes of Conduct GRI 102-17 (Comprehensive)Internal and external mechanisms for reporting concerns about unethical or unlawful behavior, and matters related to organizational integrity, such as escalation through line management, whistleblowing mechanisms or hotlinesBMS Codes of Conduct 2021 ESG Report: Ethics, Integrity, Quality and Governance >> EthicalBusiness GRI 102-18 Governance structure of the organization, including committees under the highest governance body; identify any committees responsible for decision-making on economic, environmental and social impacts2021 ESG Report: Introduction >> Our Approach to ESG Governance Board of Directors Board Committee & Charters GRI 102-19 (Comprehensive)Process for delegating authority for economic, environmental and social topics from highest governance body to senior executives and other employees2021 ESG Report: Introduction >> Our Approach to ESG; Ethics, Integrity, Quality and Governance >> Governance and Risk Management BMS Codes of Conduct GRI 102-20 (Comprehensive)Identify executive-level position with responsibility for economic, environmental and social topics and reporting to highest governance body2021 ESG Report: Introduction >> Our Approach to ESG Leadership Team GRI 102-21 (Comprehensive)Mechanisms for consultation between stakeholders and highest governance body on economic, environmental and social topicsBMS Codes of Conduct GRI 102-22 (Comprehensive)Composition of the highest governance body and its committees2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management Corporate Governance Guidelines Board of Directors GRI 102-23 (Comprehensive)Indicate whether the Chair of the highest governance body is also an executive officer, and if so, reason for this arrangementGovernance Board of Directors GRI 102-24 (Comprehensive)Report the nomination and selection processes for the highest governance body and its committees, and the criteria used for nominating and selecting highest governance body membersCorporate Governance Guidelines Composition and structure of the Board Committee on Directors and Corporate Governance 2021 ESG REPORT | 64 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 102-25 (Comprehensive)Processes in place for the highest governance body to ensure conflicts of interest are avoided and managedCorporate Governance Guidelines Board ResponsibilitiesItem 4 Compliance, Ethics and Conflicts of Interest GRI 102-26 (Comprehensive)Role of highest governance body and senior executives in developing, approving, and updating the purpose, value, or mission statements, strategies, policies and goals related to economic, environmental and social impacts2021 ESG Report: Introduction >> Our Approach to ESG; Environmental Responsibility >> Our Approach Environmental, Health and Safety Policy GRI 102-27 (Comprehensive)Measures taken to develop and enhance the highest governance body's collective knowledge of economic, environmental and social topics2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management Corporate Governance Guidelines GRI 102-28 (Comprehensive)Process for evaluating the highest governance body's own performance with respect to economic, environmental and social and if evaluation is independent or self-assessment2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management Corporate Governance Guidelines Evaluating the Boards Performance GRI 102-29 (Comprehensive)Process of the highest governance body's role for overseeing the organization's identification and management of economic, environmental, and social performance and if stakeholder consultation is used2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management; Environmental Responsibility >> Our Approach Governance Committee on Directors and Corporate Governance Charter GRI 102-30 (Comprehensive)Role of the highest governance body in reviewing the effectiveness of the organization's risk management processes for EES topics2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management Board Committee & Charters Audit Committee Charter Responsibilities and DutiesItem 10 GRI 102-31 (Comprehensive)Frequency of the highest governance body's review of EES impacts, risks, and opportunities2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management; Environmental Responsibility >> Our Approach Board Committee & Charters Committee on Directors and Corporate Governance CharterResponsibilities and Duties Items 15 and 17 GRI 102-32 (Comprehensive)Highest committee or position that formally reviews and approves the organization's sustainability report and ensures all material Aspects are coveredBMS Leadership Team GRI 102-33 (Comprehensive)Process for communicating critical concerns to the highest governance body2021 ESG Report: Ethics, Integrity, Quality and Governance >> Governance and Risk Management; Ethical Business Board Committee & Charters Systems for Managing Risks GRI 102-34 (Comprehensive)Nature and total number of critical concerns that were communicated to the highest governance body and the mechanism(s) used to address and resolve them2021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical Business GRI 102-35 (Comprehensive)Remuneration policies for highest governance body and senior executives; linkage between compensation for members of the highest governance body, senior managers, and executives, and the organization's performance2021 10-K Corporate Governance Guidelines Governance & Executive Compensation Policies Corporate Governance Guidelines Annual Evaluation of the Chief Executive Officer Compensation and Management Development Committee Charter 2021 ESG REPORT | 65 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 102-36 (Comprehensive)Process for determining remuneration Corporate Governance Guidelines Governance & Executive Compensation Policies Corporate Governance Guidelines Annual Evaluation of the Chief Executive Officer Compensation and Management Development Committee Charter GRI 102-40 List of stakeholder groups engaged by the organizationCorporate engagement: World Health Organization UN Global Compact UN Global Compact Communication on Progress 2021 Pharmaceutical Supply Chain Initiative By issue: Access to Medicines Corporate Giving Drug Donations and Philanthropic Efforts Disaster Relief and Product Donations Community Support For more on our engagement, visit our company website . The Compliance & Ethics department, under the leadership of the CCEO, publishes regular companywide memos and articles on the internal news platform to support our commitment to ethics and integrity. 2.2The percentage of business functions that are included in the anti-corruption risk assessment100% of business functions are represented in BMS anti-corruption risk assessments. Compliance standards are memorialized in third-party agreements, and BMS provides additional support where needed, such as anti-bribery training, to third parties. Oversight by this committee strengthens our ability to operate with the highest levels of quality, integrity and ethics, which are foundational to our business. 1.4Ethics and integrity are integral components in leadership decisionsOur performance management process approaches integrity at an individual level. HC-BP-510a.12021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical Business 2021 ESG Report: Appendix >> NBIM Index 2021 ESG REPORT | 62 2021 SASB IndexGlobal Reporting Initiative (GRI) 2021 Index This index aligns with the Global Reporting Initiatives 2018 Sustainability Reporting Standards. 1.3Does your performance management framework incorporate how ethics and integrity objectives are achieved? 1.2The frequency (could be a % or absolute number) of references to ethics and compliance communicated internally and/ or externally by the defined C-levelpersonsOur leadership ensures a continuous emphasis on practicing a culture of integrity. HC-BP-510a.22021 10-K Description of code of ethics governing interactions with healthcare professionals. 2021 ESG REPORT | 72Indicator Indicator Description 2021 Response Risk Management 2.1The company has an anti-corruption compliance risk program, which it uses to give regular updates to senior management and Board on how risks are being managedBMS anti-corruption compliance program is a cross-functional effort, including first-, second- and third-line risk management functions. 1.5The company actively engages in anti-corruption collective actionBMS has committed to the following anti-corruption collective action initiatives: Industry Association Codes such as the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Practice, European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice and the Pharmaceutical Research and Manufacturers of America (PhRMA) Codes. HC-BP-250a.42021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical and Safe Products Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP), by type. 1 Announced Dec 2020 2 Announced Aug 2020 2021 ESG REPORT | 8Ethics, Integrity, Quality and Governance IN THIS SECTION Ethical Business Ethical and SafeProducts Cybersecurity Governance and Risk Management 2021 ESG REPORT | 9Ethics, Integrity, Quality andGovernance From the way we grow our business to the products we make, our values and principles of integrity guide our every decision. Additionally, we maintain ongoing communication on ethics and compliance throughout the year. HC-BP-250a.22021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical and Safe Products Please visit the FAERS MedWatch page for more information. We are committed to meeting standards of governance, including taking steps to achieve greater transparency and accountability to our shareholders. The I in Integrity initiative has been rolled out across the company under the leadership of the CCEO, and has provided tools and resources to encourage and facilitate conversations related to integrity. In addition, Integrity is one of six BMS Values. HC-BP-250a.12021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical and Safe Products Please visit the FAERS MedWatch page for more information. We also embed integrity into our hiring and critical talent decisions with professional and executive interview questions to explore a candidates integrity. Integrity is one of BMS six Values, expected to be demonstrated consistently by every employee. Integrity is reflected in our companywide objective of Demonstrating ethics, integrity and quality in everything we do, which is adopted into every employees individual objectives. We are committed to quality, integrity and ethics in everything we do. It facilitates accountability and transparency by consistently sharing the outcomes of our access-to-medicine activities in a centralized manner. HC-BP-260a.32021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical and Safe Products Ethical MarketingTotal amount of monetary losses as a result of legal proceedings associated with false marketing claims. They commit us to the highest standards of ethics, integrity and quality in everything we do for patients, customers, colleagues and our communities."
Human Capital Development,"BMS is a company heavily steeped in science and research. We have evolved our core strategy for business growth tointegrate environmental, social and governance (ESG) factors. We leverage sustainability to drive innovation, build resiliency and manage nonfinancial risks.","We leverage sustainability to drive innovation, build resiliency and manage nonfinancial risks. As we integrate ESG into our strategy for growth, we consider an emphasis on health equity to be a business imperativenot only because it is central to our vision, but also because it is simply the right thing to do. Our PBRGs accelerate the development of many members, empowering them to become business leaders who add value by helping to execute BMS business plans. ESG Governance Our ESG strategy is meaningfully tied to our companys core strategy, as the opportunities and potential impacts of ESG issues are directly interrelated to our business. While resourcing is not an explicit agenda item in every meeting, these meetings provide the opportunity to address resource topics. Our commitment to health equity underscores our approach to environmental stewardship. Mapping SDG Alignment We leveraged the SDG Compass to best map our sustainability efforts across the enterprise and align our strategy to the realization of the SDGs. Looking ahead Keeping ESG integrated into our strategy, we remain steadfast in our focus on robust topline and bottomline growth, financial flexibility and a strong innovation engine. Advancing our strategy As we execute our strategy, were engaging our global workforce to make progress toward ambitious, ESG-focused goals. As we manage our environmental footprint, we consider every facet of our value chain and incorporate a science-first approach to identify opportunities through which we can make the most meaningful global impact. Each year, we leverage our business success and deepen our use of cutting-edge digital technologies to strengthen and fuel our companys innovation engine. We believe that driving long-term business value is at the heart of living our purpose, being leaders and difference-makers for generations to come. These are the first steps in building a foundation for our predictive quality vision. Primary Goals correspond to efforts that support our core value chain. Our business is growing, and we must continue to act across our global operations to reduce our environmental impact. Unless otherwise stated, this report details our performance on ESG topics and contains nonfinancial disclosures covering the period from January 1, 2021, through December 31, 2021. 2021 ESG REPORT | 20Innovation BMS is a company heavily steeped in science and research. Critically, we have evolved our core strategy for business growth tointegrate environmental, social and governance (ESG) factors."
Innovation Management,"BMS is a company heavily steeped in science and research. We have evolved our core strategy for business growth tointegrate environmental, social and governance (ESG) factors. We leverage sustainability to drive innovation, build resiliency and manage nonfinancial risks.","We leverage sustainability to drive innovation, build resiliency and manage nonfinancial risks. As we integrate ESG into our strategy for growth, we consider an emphasis on health equity to be a business imperativenot only because it is central to our vision, but also because it is simply the right thing to do. Our PBRGs accelerate the development of many members, empowering them to become business leaders who add value by helping to execute BMS business plans. ESG Governance Our ESG strategy is meaningfully tied to our companys core strategy, as the opportunities and potential impacts of ESG issues are directly interrelated to our business. While resourcing is not an explicit agenda item in every meeting, these meetings provide the opportunity to address resource topics. Our commitment to health equity underscores our approach to environmental stewardship. Mapping SDG Alignment We leveraged the SDG Compass to best map our sustainability efforts across the enterprise and align our strategy to the realization of the SDGs. Looking ahead Keeping ESG integrated into our strategy, we remain steadfast in our focus on robust topline and bottomline growth, financial flexibility and a strong innovation engine. Advancing our strategy As we execute our strategy, were engaging our global workforce to make progress toward ambitious, ESG-focused goals. As we manage our environmental footprint, we consider every facet of our value chain and incorporate a science-first approach to identify opportunities through which we can make the most meaningful global impact. Each year, we leverage our business success and deepen our use of cutting-edge digital technologies to strengthen and fuel our companys innovation engine. We believe that driving long-term business value is at the heart of living our purpose, being leaders and difference-makers for generations to come. These are the first steps in building a foundation for our predictive quality vision. Primary Goals correspond to efforts that support our core value chain. Our business is growing, and we must continue to act across our global operations to reduce our environmental impact. Unless otherwise stated, this report details our performance on ESG topics and contains nonfinancial disclosures covering the period from January 1, 2021, through December 31, 2021. 2021 ESG REPORT | 20Innovation BMS is a company heavily steeped in science and research. Critically, we have evolved our core strategy for business growth tointegrate environmental, social and governance (ESG) factors."
Access to Healthcare,"BMS is committed to providing access to its prescription medicines, including for underserved communities. We view our work through the lens of health equity. We see health equity as a critical opportunity to modernize and deepen our patient-centered purpose.The PPSWG coordinates these efforts through MED-Project. The organization implements and operates mandated household unwanted medicine and sharps takeback programs. All of these actions add up to our purposeful pursuit of better patient outcomes.","By applying a health equity lens across the product life cycle, we can accelerate inclusive innovation and expand the impact of our medicines to support medically underserved and diverse patient populations around the world. Expanding access to our medicines BMS is committed to providing access to its prescription medicines, including for underserved communities. 2021 ESG REPORT | 24Bristol Myers Squibb Foundation* Diversity in Clinical Trials Award Program The Bristol Myers Squibb Foundation, an independent charitable entity, established a program to increase the participation of diverse and underserved patents in clinical trials in the United States. We advocate for healthcare policies and infrastructure that are both sustainable and patient-centered, and we continue to advocate for improved access for vulnerable patients through our partnerships and demonstration projects. BMS is deeply committed to working alongside our partners to advance access and health equity in countries around the world. In 2021, we increased transparency on this important topic by publishing the BMS Global Access Report , which outlines our efforts, as well as our partnerships with stakeholders, to advance global healthcare access and health equity. At BMS, we remain wholly committed to facilitating broader healthcare access to help more patients prevail over serious diseases and live fuller, healthier and longer lives. Our North Star is to ensure that every patient who needs our medicines has access to them. S. through the independent BMS Patient Assistance Foundation. This report publicly discloses commitments, measurable goals, objectives and sustainability targets, including enhancing patient access to medicines. As a company dedicated to helping patients lead healthier lives, we recognize our responsibility to provide long-term benefits to society through our ESG priorities. (48)Degree 35% Male (18) 65% Female (34)Gender 67% Cancer Oncology (35)12% Immunologic Disorders (6)12% Cancer Hematology (6)10% Cardiovascular Disease (5)Specialty 2021 ESG REPORT | 25Access to Healthcare Expanding access to healthcare is one of the most important steps to helping communities thrive. 14,000 expected participants across Africa and India Oncology knowledge repository for healthcare professionals by the King Baudouin Foundation with BMS support.>200 patient outreach programs, >150 healthcare professionals trained by world-leading cancer centers and societies through the Cancer Care Links program, to address cancer care capacity building in resource-constrained countries. Most of our development programs bring together multi-month cohorts. Learn more in our 2021 10-K . To this end, we are the ongoing sponsor for the One Young World Lead2030 Challenge, which invites young innovators to design solutions to break down barriers that girls face in regard to STEM education. In 2021, our grants resulted in: >619,000 people reached >4,000 people trained 530+ educational events and convenings 85 resources and platforms created to expand disease awareness and education We view our work through the lens of health equity We see health equity as a critical opportunity to modernize and deepen our patient-centered purpose. The PPSWG coordinates these efforts through MED-Project , a stewardship organization that implements and operates mandated household unwanted medicine and sharps takeback programs. All of these actions add up to our purposeful pursuit of better patient outcomes. I&D are essential for better health outcomes for our patients. HC-BP-210a.2None Total amount of monetary losses as a result of legal proceedings associated with clinical trials in developing countries: HC-BP-210a.32021 10-K Access to MedicinesDescription of actions and initiatives to promote access to healthcare products for priority diseases and in priority countries as defined by the Access to Medicine Index. Examples of beyond the pill solutions include improving the quality of care that patients receive and helping them navigate the healthcare landscape, particularly in specialty care settings, in a way that helps them best meet their needs. Our 2021 sponsorship included a $50,000 grant and a years worth of mentorship to the winning organization, Smart Cheli, which provides robotics training and mentorship to young girls and women in Nepal. The Winn CIPP provides URM medical students a summer immersion experience in community-based clinical research in select cities with a high disease burden. Their work facilitated access to fresh and healthy food to support communities where BMS operates. To that end, we provide support for: Welcoming and nurturing family members through paid parental leave, bridge back parent leave, adoption/ surrogacy reimbursement Fertility/infertility benefits Support for traveling mothers Paid family care leave Child, elder and pet care resources Commuter accounts Paid sick time, vacation, holidays and annual paid volunteer days Paid bereavement leave Paid military leave and military family care leave 2021 ESG REPORT | 32Our vision to transform patients lives through science is made possible by the talent, passion and hard work of our employees. This will ensure that more patients can benefit from our breakthrough science and live longer, healthier lives. 2021 progress and impact 7,700+ leaders and managers had the opportunity to attend unconscious bias education training in 2021, and 1 in5 managers attended that training last yearExpanded employee access and adoption to on-demand digital learning by 52% Employees used video learning vs. e-learning heavily; resulting in a ratio of 25:1258,962 manager training video views68% of our participants were women and 51% were from UEGs 100% of our Leadership Development programs are inclusive and address topics relevant to women and UEGs15% more Leadership Development Program enrollments in 2021 versus 2020Enrollment across all programs is accounted to women by more than 50% 2021 ESG REPORT | 35Supply Chain Our promise to our patients, as well as their families and healthcare providers, is to maintain an unencumbered and uninterrupted supply of medicines that can be delivered wherever and whenever they are needed. Supporting mental health In 2021, our myVoice survey results indicated an opportunity to adjust our programs and deploy interventions to meet the needs of our workforce, and ultimately, patients. In 2021, there were >20 active unwanted medicine programs and nine sharps programs throughout the U. We have numerous programs and initiatives in place designed to listen and create spaces for patient advocates and community partners to come together, and to deliver inclusive, multilingual and culturally competent disease education and quality of care programs. The grants aimedto scale effective health equity solutions, including 24grants for proposals focused on community health workers and patient navigators."
Talent Attraction & Retention,"CNN.com will feature iReporter photos in a weekly Travel Snapshots gallery. Please submit your best shots of New York for next week. Visit CNN.com/Travel next Wednesday for a new gallery of snapshots.2021 ESG Report: Environmental Responsibility >> Energy and Emissions Energy Conservation ENERGY STAR Award CDP EPA GRI 302-2 Energy consumption outside of the organization. Report total direct energy consumption in joules or multiples by renewable/non-renewable primary source.Bristol Myers Squibb Foundation* Commitments to Health Equity and Inclusion&Diversity By 2025 Award $50 million in U . S. executives were Hispanic/Latino in 2021 vs. 4 .2% in 2020. Locate at least 25% of U. S. sites participating in new BMS clinical trials in racially and ethnically diverse metroareas.In 2021, we made progress across our commitments to health equity and inclusion and diversity (I&D). Visit the 2021 Global Inclusion & Diversity Report for more information.","Report total direct energy consumption in joules or multiples by renewable/non-renewable primary source.2021 ESG Report: Environmental Responsibility >> Energy and Emissions Energy Conservation ENERGY STAR Award CDP EPA GRI 302-2 Energy consumption outside of the organization 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 302-3 Energy intensity 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 302-4 Reduction of energy consumption 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 303-1 Total water withdrawal by source 2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 303-2 Water sources significantly affected by withdrawal of water2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 303-3 Percentage and total volume of water recycled and reused2021 ESG Report: Environmental Responsibility >> Waste and Recycling GRI 304-3 Habitats protected or restored 2021 ESG Report: Environmental Responsibility >> Employee Engagement in Sustainability GRI 304-4 Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction riskNot reported 2021 ESG REPORT | 68 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 305-1 Direct greenhouse gas emissions (Scope 1) 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-2 Indirect greenhouse gas emissions (Scope 2) 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-3 Other relevant indirect greenhouse gas emissions (Scope 3)2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-4 Greenhouse gas emissions intensity 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-5 Reduction of greenhouse gas emissions 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-6 Emissions of ozone-depleting substances (ODS) Not reported GRI 305-7 NOx, SOx, and other significant air emissions by typeNot reported GRI 306-1 Total water discharge by quality and destination 2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 306-2 Total weight of waste by type and disposal method 2021 ESG Report: Environmental Responsibility >> Waste and Recycling GRI 306-3 Total number and volume of significant spills Not reported GRI 306-4 Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally2021 ESG Report: 2021 ESG Data GRI 307-1 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations2021 10-K GRI 308-1 Percentage of new suppliers that were screened using environmental criteria2021 ESG Report: Our People >> Supply Chain Standards of Business Conduct and Ethics for Third Parties 2021 ESG REPORT | 69 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 401-2 Benefits to full time employees Benefits GRI 403-1 Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs2021 ESG Report: Our People >> Employee Health and Safety GRI 403-2 Types of injury and rates of injury, occupational diseases, lost days, and absenteeism, and total number of work-related fatalities by region and by gender2021 ESG Report: Our People >> Employee Health and Safety GRI 404-2 Programs for skills management and lifelong learning that support continued employability of employees and assist them in managing career endings.2021 ESG Report: Our People >> Global Inclusion and Diversity 2021 Global Inclusion & Diversity Report Benefits Developing Our People Development Programs GRI 405-1 Composition of governance bodies and employee breakdown per employee category by gender, age, minority group member (other diversity)2021 ESG Report: Our People >> Global Inclusion and Diversity 2021 Global Inclusion & Diversity Report GRI 408-1 Child labor incidents and measures to eliminate child laborStandards of Business Conduct and Ethics for Third Parties Bristol Myers Squibb UN Global Compact Communication on Progress 202 1 Workplace Policies GRI 409-1 Forced labor incidents and measures to eliminate forced laborWe had zero incidents of forced labor for 2021. Starting in 2021, the supplier diversity team sponsored 10 Ethnic Minority Businesses (EMBs) to this executive education program based in the United States. Our Global Inclusion & Diversity focus plays a key role in our global reputation as an employer of choice among top, diverse talent in science, technology, engineering, and math (STEM). For more information, see the Bristol Myers Squibb Global Inclusion & Diversity Report 2022 2021 ESG REPORT | 30Global management level by gender As we build representation at senior levels of our organization, we will continue to focus on the advancement of our pipeline of female talent. This strategy, along with workforce representation data, isdetailed in our Global Inclusion & Diversity Report . Health Equity and Inclusion & Diversity2 Starting in 2021 Locate at least 25% of U. Under BMS Diversity in Clinical Trials Commitment, we established the goal to locate 25% of new clinical trials in racially and ethnically diverse areas in the U. >32K employees worldwide >12.2K members of our eight People and Business Resource Groups representing 44 countries 2021 ESG REPORT | 28Global Inclusion and Diversity We are guided by a single vision to transform patients lives through science. In particular, in connection with its identification and selection of potential director nominees, the Board is committed to identifying and evaluating highly qualified women and historically underrepresented ethnic group candidates, as well as candidates with other diverse backgrounds and experiences. In line with this focus, they are prioritizing efforts to increase inclusion and diversityboth at the Board member level and throughout the organization. We foster an environment of inclusion and belonging and build a globally diverse workforce to drive equitable advancement and outcomes for all. To fully realize this vision, we have relied on the strength of our rich history and longstanding commitment to inclusion and diversity to ensure that we can drive meaningful impact and outcomes for our patients and communities, our colleagues, and our business and industry. S. sites participating in new BMS clinical trials in racially and ethnically diverse metroareas. 2021 ESG REPORT | 29Accelerated Leadership Development and Advancement We have enhanced our longstanding investments in accelerated leadership development and have developed unique and relevant content for women globally and for underrepresented racial and ethnic groups in the U. S. An independent committee selected the cohort, which represents a diverse cross-section of races and ethnicities. Bristol Myers Squibb Foundation* Commitments to Health Equity and Inclusion&Diversity By 2025 Award $50 million in U. S. executives were Hispanic/Latino in 2021 vs. 4.2% in 2020Veteran, people with disabilities and LGBTQ+ status self-identification: Everybody Counts In the U. We leverage a broad suite of programs to identify and develop future talent Insights for Success Our Insights for Success program is offered to diverse employees women, Black/African American, Latino/Hispanic and Asian Americansto enhance their organizational and personal career success and ensure equitable leadership opportunities. Visit the 2021 Global Inclusion & Diversity Report for more information. In 2021, we made progress across our commitments to health equity and inclusion and diversity (I&D). Of the 550 leaders who participated in 2020 and 2021, 68% were women and 51% were from underrepresented ethnic groups (UEGs). S.; and double executive representation of Hispanic/Latino employees in the U. Participating healthcare institutions locations Self-reported scholar demographicsETHNICIT Y GENDER DEGRE E SPECIAL TY%36.5 % Other identity * (14)Latino/Hispanic (19) Black/Afric an Americ an (19) 35%65% 0%Other (0)Male (18)Female (34)8%92% 27%M. Our evolved Global Inclusion & Diversity (GI&D) strategy and priorities are the first steps on the path forward to meaningful change. S. clinical trial sites were located in highly diverse communities, exceeding our goal Tomorrows Innovators expanded program to recruit talent from Historically Black Colleges and Universities 60% of Board Directors comprise women or underrepresented racial and ethnic groups2021 ESG Progress & Highlights 45.5% global executives are women, a 2.9% YOY increase 619,000 people reached through Health Equity grants >$704M product donations in U. Tenure and diversity of BMS Board Director Tenure Board Diversity 4Female Directors 2Black/African American Directors 1Latino/Hispanic Director60% of our directors comprise women or underrepresented racial and ethnic groups1 1 Deepak L. Double representation from June 2020 levels of both Black/African American executives (3.0% to 6.0%) and Latino/Hispanic executives (3.7% to 7.4%) in the U. 36.5 Self-reported scholar demographics Black/African American (19)36.5% Latino/Hispanic (19)36.5%Other Identity* (14)27%Ethnicity * Other Identity (not NSF-Defined Underrepresented in Medicine) = Asian (1), Caucasian (5), Middle Eastern (1), South Asian (6), West Asian (1).8% M. A focus on diversity during discovery and development leads to better science. In August of 2020, we launched our I&D and Health Equity Commitments , with a $150 million, five-year investment to help address disparities in healthcare, increase diversity in clinical trials, expand the supply chain to include more diverse suppliers, enhance our employees ability to give back to the community and increase the diversity of our own workforce. 2021 ESG REPORT | 26Our People IN THIS SECTION Global Inclusion and Diversity Accelerated Leadership Development and Advancement Employee Health andWellbeing Employee Health andSafety Learning and Development Supply Chain 2021 ESG REPORT | 27Our People We do our best work when our colleagues feel supported, included and inspired. This includes designing with flexibility in mind to account for the vast diversity of peoples skills, knowledge and needs. In addition, the percentage of employees who disclosed their gender identification and sexual orientation status grew from 6.4% to 14.8%an increase of 8.4%. The tenets of our commitment include: Value to Business: We harness the power of diversity through our suppliers. S. ethnicity by management level At the executive level Global executive gender parity U. During 2021, we hosted several cohorts in this program and offered our first cohort focused on LGBTQ+ employees. 2021 ESG REPORT | 36Supplier diversity Driving excellence across our supply chain requires a culture of inclusion at every touch point. Workforce aspirational representation goals We value an executive team that reflects the perspectives and backgrounds of the patients and communities we serve. Diversity in clinical trials is a key driver of health equity. We're also building a global workforce that reflects the diverse cultures, backgrounds and experiences of our patients and communities globally."
Health Outcome Contribution,"CNN.com will feature iReporter photos in a weekly Travel Snapshots gallery. Please submit your best shots of New York for next week. Visit CNN.com/Travel next Wednesday for a new gallery of snapshots.2021 ESG Report: Environmental Responsibility >> Energy and Emissions Energy Conservation ENERGY STAR Award CDP EPA GRI 302-2 Energy consumption outside of the organization. Report total direct energy consumption in joules or multiples by renewable/non-renewable primary source.Bristol Myers Squibb has a team of doctors and nurses that execute key occupational and medical interventions in support of our global community. We truly believe our people are our differentiators, and we reflect that in the way we support our employees. We work every day to create an environment that is devoid of work-related injuries.Diverse Business Enterprise (DBE) $695,336,854 $899,277,462 Diverse spend: Minority Business Enterprise ($450,241,075) $550,931,958 Women Business Enterprise $299,861,314 $429,985,082 Veterans Business Enterprise  $53,226,133 $56,494,195 Disability-Owned Business EnterpriseÂ  $17,942,401 $8,248,492At BMS, we strive to ensure that operations at our facilities are both environmentally responsible and protective of personal and public health and safety. We are on a journey to create a best-in-class environment, health, safety, sustainability and wellbeing program that is scientifically sound and forward leaning.","Report total direct energy consumption in joules or multiples by renewable/non-renewable primary source.2021 ESG Report: Environmental Responsibility >> Energy and Emissions Energy Conservation ENERGY STAR Award CDP EPA GRI 302-2 Energy consumption outside of the organization 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 302-3 Energy intensity 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 302-4 Reduction of energy consumption 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 303-1 Total water withdrawal by source 2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 303-2 Water sources significantly affected by withdrawal of water2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 303-3 Percentage and total volume of water recycled and reused2021 ESG Report: Environmental Responsibility >> Waste and Recycling GRI 304-3 Habitats protected or restored 2021 ESG Report: Environmental Responsibility >> Employee Engagement in Sustainability GRI 304-4 Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction riskNot reported 2021 ESG REPORT | 68 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 305-1 Direct greenhouse gas emissions (Scope 1) 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-2 Indirect greenhouse gas emissions (Scope 2) 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-3 Other relevant indirect greenhouse gas emissions (Scope 3)2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-4 Greenhouse gas emissions intensity 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-5 Reduction of greenhouse gas emissions 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-6 Emissions of ozone-depleting substances (ODS) Not reported GRI 305-7 NOx, SOx, and other significant air emissions by typeNot reported GRI 306-1 Total water discharge by quality and destination 2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 306-2 Total weight of waste by type and disposal method 2021 ESG Report: Environmental Responsibility >> Waste and Recycling GRI 306-3 Total number and volume of significant spills Not reported GRI 306-4 Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally2021 ESG Report: 2021 ESG Data GRI 307-1 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations2021 10-K GRI 308-1 Percentage of new suppliers that were screened using environmental criteria2021 ESG Report: Our People >> Supply Chain Standards of Business Conduct and Ethics for Third Parties 2021 ESG REPORT | 69 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 401-2 Benefits to full time employees Benefits GRI 403-1 Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs2021 ESG Report: Our People >> Employee Health and Safety GRI 403-2 Types of injury and rates of injury, occupational diseases, lost days, and absenteeism, and total number of work-related fatalities by region and by gender2021 ESG Report: Our People >> Employee Health and Safety GRI 404-2 Programs for skills management and lifelong learning that support continued employability of employees and assist them in managing career endings.2021 ESG Report: Our People >> Global Inclusion and Diversity 2021 Global Inclusion & Diversity Report Benefits Developing Our People Development Programs GRI 405-1 Composition of governance bodies and employee breakdown per employee category by gender, age, minority group member (other diversity)2021 ESG Report: Our People >> Global Inclusion and Diversity 2021 Global Inclusion & Diversity Report GRI 408-1 Child labor incidents and measures to eliminate child laborStandards of Business Conduct and Ethics for Third Parties Bristol Myers Squibb UN Global Compact Communication on Progress 202 1 Workplace Policies GRI 409-1 Forced labor incidents and measures to eliminate forced laborWe had zero incidents of forced labor for 2021. We work every day to create an environment that is devoid of work-related injuries and illnesses, predicated on proactive risk identification and systemic solutioning. S. Occupational Safety and Health Administration (OSHA) for recording occupational accidents and illnesses worldwide. Occupational Health Our Occupational Health approach involves a team of doctors and nurses that execute key occupational and medical interventions in support of our global community. S. and PR 2021 ESG REPORT | 33 Employee Health and WellbeingEmployee Health and Safety At Bristol Myers Squibb, the health, safety and wellbeing of our workforces are our priority. The physicians and nurses in these departments provide a range of health services including: Emergency medical care Treatment of work-related illness and injuries Safety awareness training Work-site health evaluations Risk-based medical surveillance Urgent medical care Reproductive health program Wellness consultations We truly believe our people are our differentiators, and we reflect that in the way we support our employees. These include: a Safety Center of Excellence, an Environmental Center of Excellence, a Systems and Assurance Center of Excellence, an Occupational Health and Wellbeing Center of Excellence and a Sustainability Center of Excellence. S. 3.7% 7.2% 2021 ESG REPORT | 542021 employee safety performance Business EHS inspectionsCAPA completed &closedFull investigations closedNear miss/unsafe condition reports/ 100 employees Commercial 5 7 15 Enabling functions 17 17 GPS 7,071 2,094 975 59 R&ED 2,793 52 88 35 Service provider 301 128 Total 9,864 2,469 1,215 109 SIF incident SIF near miss Motor vehicle accident 7 Pressure 7 Hazardous materials 14 Working from heights 19 Machine guarding Overhead hazards 2 Control of hazardous energy 1 5 Electrical 3 Process safety Other 16 Total 1 73 2021 ESG REPORT | 55 2021 ESG DataTopic 2020 2021 Suppliers Diverse spend: Diverse Business Enterprise (DBE) $695,336,854 $899,277,462 Diverse spend: Minority Business Enterprise (MBE) $450,241,075 $550,931,958 Diverse spend: Women Business Enterprise (WBE) $299,861,314 $429,985,082 Diverse spend: Veterans Business Enterprise (VBE) $53,226,133 $56,494,195 Diverse spend: Disability-Owned Business Enterprise (DOBE) $17,942,401 $8,248,492 Diverse spend: LGBT Business Enterprise (LGBTBE) $10,917,260 $15,309,109 Actual percent: Diverse Business Enterprise (DBE) 13.6% 15.3% Actual percent: Minority Business Enterprise (MBE) 8.8% 9.4% Actual percent: Women Business Enterprise (WBE) 5.9% 7.3% Actual percent: Veterans Business Enterprise (VBE) 1.0% 1.0% Actual percent: Disability-Owned Business Enterprise (DOBE) 0.4% 0.5% Actual percent: LGBT Business Enterprise (LGBTBE) 0.2% 0.3% Actual percent: Diverse Business Enterprise (DBE) 13.6% 15.3% Internal SS&P area goal Diverse Business Enterprise (DBE) 12.0% 12.7% Internal SS&P area goal Minority Business Enterprise (MBE) 8.2% 6.3% Internal SS&P area goal Women Business Enterprise (WBE) 3.9% 4.8% Internal SS&P area goal Veterans Business Enterprise (VBE) 0.7% 0.7% Internal SS&P area goal Disability-Owned Business Enterprise (DOBE) 0.2% 0.1% Product Compounds in development across platforms 50+ 50+ Disease areas being studied 40+ 60+ Marketed product families 46 43 External contract manufacturing sites 100+ 140+ Active development programs 54 100 No observable impact from COVID-19 including no drug shortages impacting patients 0 0 Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP) by type 0 0 Products listed in the FDA MedWatch Safety Alerts for Human Medical Products database 0 0 Number of fatalities associated with products as reported in the FDA Adverse Event Reporting System 0 0 Number of recalls issued; total units recalled 0 0 Partnering to speed transformational medicines to patients: Development pipeline is externally sourced 60% 60% Active alliances, collaborations and partnerships 300+ 300+ 2021 ESG REPORT | 56 2021 ESG DataTopic 2019 2020 2021 Environment* T otal greenhouse gas emissions (CO 2e); thousands of metric tons Scope 1 (Direct) 218.2 202.4 204.3 Scope 2 (Indirect market-based) 118.6 122.6 166.3 Total (Scope 1+2) from operations 336.8 325.0 370.5 Scope 3 (Category 1 Purchased goods & services) 1,641.9 Scope 3 (Category 2 Capital goods) 18.1 Scope 3 (Category 3 Fuel- & energy-related activities) 82.6 Scope 3 (Category 4 Upstream transportation & distribution) 77.0 Scope 3 (Category 5 Waste generated in operations) 4.4 Scope 3 (Category 6 Business travel) 103.3 17.7 10.9 Scope 3 (Category 7 Employee commuting) 54.7 Scope 3 total 1,889.6 Total (Scope 1+2+3) 2,260.1 T otal energy use Total energy use; millions of gigajoules Scope 1 (Direct) 4.1 3.8 3.9 Scope 2 (Indirect) 1.8 1.7 1.6 Total (Scope 1+2) 5.9 5.5 5.5 Waste generated; millions of kilograms Hazardous 0.7 0.2 1.9 Nonhazardous 4.4 1.3 4.3 Recycled/reused 8.1 3.4 5.6 Total 13.2 4.8 11.7 Water use Water use; billion liters 3.1 3.1 3.2 2021 ESG REPORT | 57 2021 ESG Data*Explanation of Scope 3 emissions calculations Sources of Scope 3 emissionsEvaluation statusEmissions in reporting year (metric tons CO 2e)Emissions calculation methodologyPercentage of emissions calculated using data obtained from suppliers or value chain partnersExplanation Purchased goods and servicesRelevant, calculated1,641,931 Hybrid approach 22% Bristol Myers Squibb uses a hybrid approach to calculate Purchased Goods and Services emissions by collecting supplier-specific data via the CDP Supply Chain program as well as spend data for suppliers outside of that program. Our EHS management system and our occupational health manual outline the regulatory and company requirements that underpin our operations globally. At BMS, we strive to ensure that operations at our facilities are both environmentally responsible and protective of personal and public health and safety, starting by designing clean and efficient manufacturing processes, and routinely assessing existing facility operations. Integrating universal design In alignment with our commitment to employee health, safety and wellness, BMS has committed to the adoption of universal design to help ensure our buildings are accessible. Regulations and standards Our sector is one of the most highly regulated industries because human health and lives are at stake. We are on a journey to create a best-in-class environment, health, safety, sustainability and wellbeing program that is scientifically sound and forward leaning. Allies are not trained therapists and do not diagnose mental health illness. As a company driven by science, we understand that human health is inextricably linked to the health of the planet, therefore we consider environmental responsibility to be imperative for doing business and expanding health equity around theworld. Accordingly, our governance model links core business considerations with our ESG framework and ensures engagement and alignment from BMS most senior leaders, with core support from key functional areas such as Corporate Affairs and Legal, including Environment, Occupational Health, Safety and Sustainability (EOHSS) and is integrated into our enterprise risk management (ERM) program as described below. As part of the Mental Health First Aid program from Mental Health First Aid International , allies are trained to identify, understand and respond to signs of mental distress, illness and addiction issues. We introduced BMS Mental Health Ally, a volunteer-led program that seeks to destigmatize and normalize conversations around mental health and promote the successful management of mental wellbeing. We also collaborate with the public, along with government, industry and educational organizations, to support regulations, research and programs that address environmental, health and safety concerns throughout our industry. SASB-HC-BP-250A.1Number of fatalities associated with products as reported in theFDA Adverse Event Reporting System. BMS Supports Wellbeing We understand that our employees have unique personal priorities outside of work as well. Around the globe, we promote health equity and seek to improve health outcomes for populations disproportionately affected by serious diseases. BMSapproach to wellbeing transcends the traditional wellness profilefocusing on the confluence of emotional, financial and physical wellbeing. These results indicate that we are creating an environment of trust and psychological safety where employees feel they can disclose the full spectrum of their identity at BMS. We establish safe discharge concentrations for our internal/external manufacturing processes that assess potential environmental impacts, and identify ways to minimize any potential environmental or human health impacts from discharge. Principles of universal design1 Equitable use to provide same means of use for all users regardless ofabilities2 Flexibility in use to accommodate a wide range of individual preferences and abilities 3 Simple and intuitive useto accommodate users experience, knowledge, language skills, or current concentration level 4 Perceptible informationto ensure effective communication ofnecessary information totheuser, regardless of ambient conditions or theuserssensory abilities5 Tolerance for error to minimize hazards andthe adverse consequencesof accidental or unintended actions6 Low physical effort to allow design to be used efficiently and comfortably and with a minimum of fatigue7 Size and space for approach and use to enable approach, reach, manipulation, and use regardless of users body size, posture, ormobility Enabling electric vehicle use As our employees returned to their offices in 2021, we experienced increased participation and utilization in our charging station program for electric vehicles (EVs) and hybrid plug-in cars. S., PR, Canada and Japan Wellbeing and burnout presentations and Wellbeing Mindset initiatives Gympass, offering access to gyms and fitness classes, launched in the U."
Operational Eco-Efficiency,"Twenty BMS sites are participating in the ENERGY STAR Challenge for Industry. The challenge is a global call to action for industrial sites to reduce their energy intensity by 10% within five years. The PV arrays carry a maximum output of nearly 3 .4 MW, which is equivalent to the energy needed to power more than 300 homes. This is a first, and a key step toward our goal of 100% of purchased electricity from renewable sources by 2030.2021 ESG Report: Environmental Responsibility >> Energy and Emissions Energy Conservation ENERGY STAR Award CDP EPA GRI 302-2 Energy consumption outside of the organization. Report total direct energy consumption in joules or multiples by renewable/non-renewable primary source.By 2040 Achieve net neutrality in Scope 1 (direct) and Scope2(indirect) GHG emissions. These efforts are voluntary, apply primarily to Scope 1 and 2 energy use and emissions, and are estimated to save approximately $520,000 annually. Nearly 7% of our total imported electricity originates from renewable sources.","Designing energy-efficient facilities Twenty BMS sites (100% of those that are eligible) are participating in the ENERGY STAR Challenge for Industry. The challenge is a global call to action for industrial sites to reduce their energy intensity by 10% within five years. The PV arrays carry a maximum output of nearly 3.4 MW, which is equivalent to the energy needed to power more than 300 homes. This is a first, and a key step toward our goal of 100% of purchased electricity from renewable sources by 2030. We recognize the importance of managing Scope 3 emissions, as they represent our biggest GHG outputs. By 2030 100% of our purchased electricity will be obtainedfromrenewable sources. Despite the impacts of COVID-19, in 2021, we continued to find ways to drive efficiency through internally run virtual treasure hunt eventsefforts that led us to implement 24 energy and water reduction measures across the portfolio. In 2021, our facilities took action to reduce greenhouse gas (GHG) emissions, increase energy efficiency and reduce waste and water usein line with our 2030 and 2040 environmental goals. In 2021, we followed the GHG Protocol to measure GHG emissions for the seven Scope 3 categories of greatest impact to our emissions profile. 4 Direct CO 2 emissions from biologically sequestered carbon, reported separately from the scopes; per GHG Protocol Corporate Accounting and Reporting Standard. In 2021, we measured GHG emissions for our Scope 1, Scope 2 and seven categories of Scope3 and had this data externally verified with limitedassurance. Report total direct energy consumption in joules or multiples by renewable/non-renewable primary source.2021 ESG Report: Environmental Responsibility >> Energy and Emissions Energy Conservation ENERGY STAR Award CDP EPA GRI 302-2 Energy consumption outside of the organization 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 302-3 Energy intensity 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 302-4 Reduction of energy consumption 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 303-1 Total water withdrawal by source 2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 303-2 Water sources significantly affected by withdrawal of water2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 303-3 Percentage and total volume of water recycled and reused2021 ESG Report: Environmental Responsibility >> Waste and Recycling GRI 304-3 Habitats protected or restored 2021 ESG Report: Environmental Responsibility >> Employee Engagement in Sustainability GRI 304-4 Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction riskNot reported 2021 ESG REPORT | 68 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 305-1 Direct greenhouse gas emissions (Scope 1) 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-2 Indirect greenhouse gas emissions (Scope 2) 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-3 Other relevant indirect greenhouse gas emissions (Scope 3)2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-4 Greenhouse gas emissions intensity 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-5 Reduction of greenhouse gas emissions 2021 ESG Report: Environmental Responsibility >> Energy and Emissions GRI 305-6 Emissions of ozone-depleting substances (ODS) Not reported GRI 305-7 NOx, SOx, and other significant air emissions by typeNot reported GRI 306-1 Total water discharge by quality and destination 2021 ESG Report: Environmental Responsibility >> Water and Wastewater GRI 306-2 Total weight of waste by type and disposal method 2021 ESG Report: Environmental Responsibility >> Waste and Recycling GRI 306-3 Total number and volume of significant spills Not reported GRI 306-4 Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally2021 ESG Report: 2021 ESG Data GRI 307-1 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations2021 10-K GRI 308-1 Percentage of new suppliers that were screened using environmental criteria2021 ESG Report: Our People >> Supply Chain Standards of Business Conduct and Ethics for Third Parties 2021 ESG REPORT | 69 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 401-2 Benefits to full time employees Benefits GRI 403-1 Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs2021 ESG Report: Our People >> Employee Health and Safety GRI 403-2 Types of injury and rates of injury, occupational diseases, lost days, and absenteeism, and total number of work-related fatalities by region and by gender2021 ESG Report: Our People >> Employee Health and Safety GRI 404-2 Programs for skills management and lifelong learning that support continued employability of employees and assist them in managing career endings.2021 ESG Report: Our People >> Global Inclusion and Diversity 2021 Global Inclusion & Diversity Report Benefits Developing Our People Development Programs GRI 405-1 Composition of governance bodies and employee breakdown per employee category by gender, age, minority group member (other diversity)2021 ESG Report: Our People >> Global Inclusion and Diversity 2021 Global Inclusion & Diversity Report GRI 408-1 Child labor incidents and measures to eliminate child laborStandards of Business Conduct and Ethics for Third Parties Bristol Myers Squibb UN Global Compact Communication on Progress 202 1 Workplace Policies GRI 409-1 Forced labor incidents and measures to eliminate forced laborWe had zero incidents of forced labor for 2021. S.-based companies that have reduced GHG emissions while growing earnings, and our scientists received the U. By 2040 Achieve net neutrality in Scope 1 (direct) and Scope2(indirect) GHG emissions. These efforts are voluntary, apply primarily to Scope 1 and 2 energy use and emissions, and are estimated to save approximately $520,000 annually, for which the related investment was approximately $1.5 million. S. Today, nearly 7% of our total imported electricity originates from renewable sources. Downstream transportation and distributionNot relevant, explanation provided All Transportation & Distribution data had an associated spend, and therefore emissions from T&D have been allocated to Category 4 based on GHG Scope 3 Standard that says: ""Outbound transportation and distribution services that are purchased by the reporting company are excluded from Category 9 and included in Category 4 (Upstream transportation and distribution) because the reporting company purchases the service. We align our approaches to the intent of the UN Paris Climate Accord and seek to instill learnings from the EPAs Greenhouse Gas Reporting program. Our Scope 3 data, along with our Scope 1 and Scope 2 GHG emissions data, has been externally verified with limited assurance. Additional information on our GHG emissions calculation methodologies and assurance certificates can be found in the Appendix . The indicator covers scope 1 of the WRI/WBCSD GHG Protocol. 2019-PRESENT, SUSTAINABILITY METRICS ENERGY/GHG 2019 (BASELINE) 2021 19-21 % Change Revenue (million USD) 26,145146,385 77% Employees 30,000132,200 7% ENERGY USE (million gigajoules, unless otherwise noted) Scope 1 Direct Energy 4.1 3.9 (7%) Scope 2 Indirect Energy 1.8 1.6 (9%) Total Energy Use Scope 1 & 2 5.925.4 (7%) GREENHOUSE GAS (GHG) EMISSIONS (metric tons of CO 2 equivalent, unless otherwise noted) Scope 1 Direct GHG from Operations 218,186 204,271 (6%) Scope 2 Indirect GHG from Operations (Market-Based) 118,574 166,250 40%3 Scope 3 Indirect GHG from Value Chain 1,889,555 Category 1 Purchased Goods & Services 1,641,931 Category 2 Capital Goods 18,050 Category 3 Fuel & Energy Related Activities 82,560 Category 4 Upstream Transportation & Distribution 76,969 Category 5 Waste Generated in Operations 4,442 Category 6 Business Travel 103,300 10,862 (89%) Category 7 Employee Commuting 54,740 Biogenic Carbon 782 711 (9%)4 Total GHG from Operations Scope 1 & 2 336,7592370,521 10%3 Total GHG Scope 1, 2 & 3 2,260,075 1 Includes Celgene results from November 20, 2019 through December 31, 2019. The work required to achieve our energy and GHG emissions goals is currently underway across our facilities, R&D labs, production sites and offices around the world. Employee commuting Relevant, calculated 54,740 Average data method0% Data was estimated using the GHG Protocol Quantis Scope 3 Evaluator for which the number of BMS employees was leveraged as an input. Our 2021 solar photovoltaic (PV) footprint includes PV arrays installed at three New Jersey locations, as well as locations in China and the U. In addition, more than $2.3 million in funding was approved to support site-based projects across the BMS enterprise to drive increase in energy efficiency and reduction of GHG emissions. We have made a series of process improvements by optimizing pump staging, replacing a boiler, improving a transformer, replacing low-efficiency motors, etc. Our Green Labs certification program encourages employees to reduce their environmental impact by minimizing their work-based energy usage, water usage and waste. Fuel- and energy-related activitiesRelevant, calculated82,560 Average data method0% Data was obtained directly from fuel and electric power consumption data tracked from invoices or other actual activity data used in the Scope 1 and 2 emissions calculations. In 2022, we expect to continue our commitment to sustainability with further reductions in carbon dioxide emissions, such as with the transition from RKN active shipping containers to thermal blankets, potentially saving up to 25kg of CO 2e per insulated pallet, as well as landfill waste reductions.2021 Highlights Reduced CO 2 emissions by 33% with the implementation of new shipping containers in two key shipping lanes 100% reduction in Sulphur Oxide, 91% reduction in Nitrogen Oxide, and 29% reduction in Carbon Dioxide through the conversion of barges to ocean vessels powered by Liquified Natural Gas (LNG) between the U. 2021 ESG REPORT | 47Embracing clean and renewable energy BMS currently manages an on-site EV charging network consisting of 155 EV charging points and more than 500 subscribers across 10 U. These goals include achieving a 10% reduction in our energy use and GHG emissions intensity, a 25% reduction in waste to landfill and a 5% reduction in water intensity. Most notably, 12 HVAC projects have been implemented across the network for which we are anticipating a reduction of over 1,154.4 mtons CO 2e annually. We procure green electricity via electric supply contracts in local markets in Ireland, Germany and California in the U. Our aim is to follow the science and creatively apply technology and our know-how to solve tough business problems of diminishing resources, carbon emissions, energy consumption and waste generation. Doing so presents opportunities to expand our overall positive impact, as our Scope 3 emissions can be a partnering companys Scope 1 or Scope 2 emissions. Learn more in BMS Household-Generated Sharps Management Plan . 2021 ESG REPORT | 58 2021 ESG Data*Explanation of Scope 3 emissions calculations Sources of Scope 3 emissionsEvaluation statusEmissions in reporting year (metric tons CO 2e)Emissions calculation methodologyPercentage of emissions calculated using data obtained from suppliers or value chain partnersExplanation Upstream transportation and distributionRelevant, calculated76,969 Hybrid approach 5% Data was obtained directly from our upstream logistics carriers. Table 9 of the EPA GHG Emission Factors Hub for Scope 3: Waste Generated in Operations was used to determine appropriate emission factors for calculations. We focused on optimizing operational efficiency, deploying more efficient sequences of operation and implementing key capital upgrades."
Product Quality & Recall Management,"In 2021, we continued to achieve exceptional product safety performance and results with zero incidents. No observable impact from COVID-19, including no drug shortages impactingpatients.Diverse Business Enterprise (DBE) $695,336,854 $899,277,462 Diverse spend: Minority Business Enterprise ($450,241,075) $550,931,958 Women Business Enterprise $299,861,314 $429,985,082 Veterans Business Enterprise  $53,226,133 $56,494,195 Disability-Owned Business EnterpriseÂ  $17,942,401 $8,248,4922021 ESG Report: Ethics, Integrity, Quality and Governance. Ethical and Safe Products; Innovation, Equity and Access to Healthcare; Clinical Trials; Environmental Responsibility. Water and Wastewater >> Pharmaceuticals in the Environment (PiE) Clinical Trials & Research Sharps Management Plan.SASB-HC-BP-250A .3 1 Data as per SASB requirements from source www .fda .gov/safety 2021 ESG REPORT | 13 Ethical and Safe Products.","Throughout our value chain, we take special care to ensure that we meet safety, efficacy, purity and quality standardsfrom design and development to manufacturing and distribution to proper methods of disposal. 2021 product safety highlights At BMS, we believe that one safety incident is one too many. HC-BP-240b.22021 ESG Report: Innovation, Equity and Access to Healthcare >> Access to Healthcare Drug SafetyList of products listed in the Food and Drug Administration's (FDA) MedWatch Safety Alerts for Human Medical Products Database. 2021 product safety results Zero1No observable impact from COVID-19, including no drug shortages impactingpatients Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP) by type. In 2021, we continued to achieve exceptional product safety performance and results with zero incidents, maintaining the quality of our products for the patients who rely on them. These capabilitiesoriginally developed to meet government regulations aimed at protecting patient safetymay be leveraged to enable a customer-specific experience and the delivery of patient-specific medicines. Product safety Providing safe products is a top priority at BMS. S. 3.7% 7.2% 2021 ESG REPORT | 542021 employee safety performance Business EHS inspectionsCAPA completed &closedFull investigations closedNear miss/unsafe condition reports/ 100 employees Commercial 5 7 15 Enabling functions 17 17 GPS 7,071 2,094 975 59 R&ED 2,793 52 88 35 Service provider 301 128 Total 9,864 2,469 1,215 109 SIF incident SIF near miss Motor vehicle accident 7 Pressure 7 Hazardous materials 14 Working from heights 19 Machine guarding Overhead hazards 2 Control of hazardous energy 1 5 Electrical 3 Process safety Other 16 Total 1 73 2021 ESG REPORT | 55 2021 ESG DataTopic 2020 2021 Suppliers Diverse spend: Diverse Business Enterprise (DBE) $695,336,854 $899,277,462 Diverse spend: Minority Business Enterprise (MBE) $450,241,075 $550,931,958 Diverse spend: Women Business Enterprise (WBE) $299,861,314 $429,985,082 Diverse spend: Veterans Business Enterprise (VBE) $53,226,133 $56,494,195 Diverse spend: Disability-Owned Business Enterprise (DOBE) $17,942,401 $8,248,492 Diverse spend: LGBT Business Enterprise (LGBTBE) $10,917,260 $15,309,109 Actual percent: Diverse Business Enterprise (DBE) 13.6% 15.3% Actual percent: Minority Business Enterprise (MBE) 8.8% 9.4% Actual percent: Women Business Enterprise (WBE) 5.9% 7.3% Actual percent: Veterans Business Enterprise (VBE) 1.0% 1.0% Actual percent: Disability-Owned Business Enterprise (DOBE) 0.4% 0.5% Actual percent: LGBT Business Enterprise (LGBTBE) 0.2% 0.3% Actual percent: Diverse Business Enterprise (DBE) 13.6% 15.3% Internal SS&P area goal Diverse Business Enterprise (DBE) 12.0% 12.7% Internal SS&P area goal Minority Business Enterprise (MBE) 8.2% 6.3% Internal SS&P area goal Women Business Enterprise (WBE) 3.9% 4.8% Internal SS&P area goal Veterans Business Enterprise (VBE) 0.7% 0.7% Internal SS&P area goal Disability-Owned Business Enterprise (DOBE) 0.2% 0.1% Product Compounds in development across platforms 50+ 50+ Disease areas being studied 40+ 60+ Marketed product families 46 43 External contract manufacturing sites 100+ 140+ Active development programs 54 100 No observable impact from COVID-19 including no drug shortages impacting patients 0 0 Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP) by type 0 0 Products listed in the FDA MedWatch Safety Alerts for Human Medical Products database 0 0 Number of fatalities associated with products as reported in the FDA Adverse Event Reporting System 0 0 Number of recalls issued; total units recalled 0 0 Partnering to speed transformational medicines to patients: Development pipeline is externally sourced 60% 60% Active alliances, collaborations and partnerships 300+ 300+ 2021 ESG REPORT | 56 2021 ESG DataTopic 2019 2020 2021 Environment* T otal greenhouse gas emissions (CO 2e); thousands of metric tons Scope 1 (Direct) 218.2 202.4 204.3 Scope 2 (Indirect market-based) 118.6 122.6 166.3 Total (Scope 1+2) from operations 336.8 325.0 370.5 Scope 3 (Category 1 Purchased goods & services) 1,641.9 Scope 3 (Category 2 Capital goods) 18.1 Scope 3 (Category 3 Fuel- & energy-related activities) 82.6 Scope 3 (Category 4 Upstream transportation & distribution) 77.0 Scope 3 (Category 5 Waste generated in operations) 4.4 Scope 3 (Category 6 Business travel) 103.3 17.7 10.9 Scope 3 (Category 7 Employee commuting) 54.7 Scope 3 total 1,889.6 Total (Scope 1+2+3) 2,260.1 T otal energy use Total energy use; millions of gigajoules Scope 1 (Direct) 4.1 3.8 3.9 Scope 2 (Indirect) 1.8 1.7 1.6 Total (Scope 1+2) 5.9 5.5 5.5 Waste generated; millions of kilograms Hazardous 0.7 0.2 1.9 Nonhazardous 4.4 1.3 4.3 Recycled/reused 8.1 3.4 5.6 Total 13.2 4.8 11.7 Water use Water use; billion liters 3.1 3.1 3.2 2021 ESG REPORT | 57 2021 ESG Data*Explanation of Scope 3 emissions calculations Sources of Scope 3 emissionsEvaluation statusEmissions in reporting year (metric tons CO 2e)Emissions calculation methodologyPercentage of emissions calculated using data obtained from suppliers or value chain partnersExplanation Purchased goods and servicesRelevant, calculated1,641,931 Hybrid approach 22% Bristol Myers Squibb uses a hybrid approach to calculate Purchased Goods and Services emissions by collecting supplier-specific data via the CDP Supply Chain program as well as spend data for suppliers outside of that program. Products listed in the FDA MedWatch Safety Alerts for Human Medical Products database. 2021 ESG REPORT | 61Topic Code/Metric Response/Reference Drug Safety (cont. That is why our unwavering commitment to product safety and quality is so essentialit is at the core of our work to bring forward medicines that transform patients lives. We are committed to transparency in reporting the environmental data we collect, and have made information related to APIs available to the public through various partnership initiatives (e.g., iPiE*SUM, FASS database) and on our product Safety Data Sheets . HC-BP-000.B2021 ESG Report: Innovation, Equity and Access to Healthcare >> Innovation Safety of Clinical Trial ParticipantsDiscussion, by world region, of management process for ensuring quality and patient safety during clinical trials. While accounting for the complexity and length of clinical trials, we design and launch programs to determine product safety and efficacy and meet health authority expectations for new product or indication applications. Workplace Policies Principles of Integrity: BMS Standards of Business Conduct and Ethics GRI 410-1 Security personnel trained to understand human rightsWorkplace Policies Workplace PoliciesSecurity GRI 412-1 Percentage and total number of operations that have been subject to human rights reviews and/or impact assessmentsHuman Rights Bristol Myers Squibb UN Global Compact Communication on Progress 202 1 GRI 414-1 Percentage of new suppliers that were screened using social criteriaBristol Myers Squibb UN Global Compact Communication on Progress 202 1 GRI 415-1 Total value of financial and in-kind contributions to political parties, politicians, and related institutions by country2021 Corporate Contributions by State GRI 416-1 Percentage of significant product and service categories for which health and safety impacts are assessed for improvement2021 ESG Report: Ethics, Integrity, Quality and Governance >> Ethical and Safe Products; Innovation, Equity and Access to Healthcare >> Clinical Trials; Environmental Responsibility >> Water and Wastewater >> Pharmaceuticals in the Environment (PiE) Clinical Trials & Research Sharps Management Plan 2021 ESG REPORT | 70 2021 GRI IndexUN SDG AlignmentGRI StandardDescription 2021 Response GRI 416-2 Total number of incidents of non-compliance with regulations and voluntary codes concerning health and safety impacts of products and services during their life cycle, by type of outcomesClinical Trials Disclosure Clinical Trials & Research GRI 417-1 Type of product and service information required by procedures, and percentage of significant products and services subject to such information requirementsOur Medicines GRI 417-3 Total number of incidents of non-compliance with regulations and voluntary codes concerning marketing communications, including advertising, promotion, and sponsorship by type of outcomes2021 10-K GRI 419-1 Non-compliance with laws and regulations in the social and economic areaPrinciples of Integrity BMS Standards of Business Conduct and Ethics 2021 10-K Compliance and Remediation Data Privacy, page 7 2021 ESG REPORT | 71 2021 GRI IndexNorges Bank Investment Management (NBIM) 2021 Index Indicator Indicator Description 2021 Response Culture 1.1A baseline has been established to identify perceptions of the ethical culture/culture of integrity in the company. Interwoven into the reporting or detection programs are time-bound processes that initiate product recall and subsequent testing as appropriate and in concert with the regulatory authorities. In this regard, one of the most important actions we take is to monitor and evaluate safety data associated with our marketed medicines and our investigational drugs in clinical trials. SASB-HC-BP-250A.3 1 Data as per SASB requirements from source www.fda.gov/safety 2021 ESG REPORT | 13 Ethical and Safe ProductsMaintaining product traceability, preventing counterfeiting SASB - HC-BP-260a.1 Supply chain digitization (previously known as global serialization) ensures that BMS is compliant with track and trace regulations. Our QMS is designed to meet or exceed global, industry-recognized standards and guidelines to build a comprehensive quality framework that is agile enough to respond to change, and robust enough to advance novel and differentiating technologies inclusive of devices and combination products. To ensure that we meet our worldwide safety reporting requirements, employees, consultants, and independent contractors must promptly report any potential or actual adverse events, as well as other events associated with our products when they become aware of them."
